SB
NVO

SIG Brokerage’s Novo Nordisk NVO Stock Holding History

SIG Brokerage’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$735K Hold
20,000
– – 0.02% 473
2025
Q4 		$1.02M Sell
20,000
-20,000
-50% -$1.02M 0.03% 360
2025
Q3 		$2.22M Buy
40,000
+30,000
+300% +$1.76M 0.06% 236
2025
Q2 		$690K Sell
10,000
-2,400
-19% -$163K 0.02% 414
2025
Q1 		$861K Sell
12,400
-45,100
-78% -$3.72M 0.04% 279
2024
Q4 		$4.95M Buy
+57,500
New +$6.22M 0.26% 63

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

SIG Brokerage's NVO Position: Q4 2025 in Review

SIG Brokerage sold out of Novo Nordisk (NVO) in Q4 2025, closing a stake of 3,986 shares — an estimated $204K sold.

SIG Brokerage first reported a position in NVO in Q4 2024 and held it in 3 quarters. The position peaked at $4.27M in Q4 2024. 1,413 funds tracked by Wall St. Rank hold NVO as of Q4 2025.

  • SIG Brokerage reported no remaining Novo Nordisk position as of Q4 2025 after selling out during the quarter.
  • SIG Brokerage sold 3,986 Novo Nordisk shares in Q4 2025, an estimated $204K.
  • SIG Brokerage first reported a position in Novo Nordisk in Q4 2024 and held it in 3 quarters.
  • SIG Brokerage's Novo Nordisk position peaked at $4.27M in Q4 2024.
  • 1,413 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2025.

Based on SIG Brokerage's 13F filing for Q4 2025, filed 17 Feb 2026.